Phase one trial explores novel immunotherapy for breast cancer

Breast Cancer News

Phase one trial explores novel immunotherapy for breast cancer
CancerClinical TrialImmunotherapy
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 26 sec. here
  • 21 min. at publisher
  • 📊 Quality Score:
  • News: 80%
  • Publisher: 71%

A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been accepted for publication in JAMA Oncology.

Kent State UniversityDec 5 2024 A groundbreaking phase one clinical trial exploring a novel cell-based immunotherapy for breast cancer has been accepted for publication in JAMA Oncology . The technology tested in the trial was co-developed by Gary Koski, Ph.D., professor in Kent State University's Department of Biological Sciences, and Brian J. Czerniecki, M.D., Ph.D., chair and senior member in the Moffitt Cancer Center's Department of Breast Oncology .

"We are hopeful that we will be able to use this new immunotherapy instead of chemotherapy, or at least dramatically reduce the need for chemotherapy, for all types of breast cancer," Czerniecki said. Eight out of the 12 patients demonstrated at least a 50% reduction in tumor volume after just six weeks of immunotherapy. This treatment produced only minimal side effects, primarily mild flu-like symptoms, compared with the severe side effects often associated with traditional chemotherapy.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Cancer Clinical Trial Immunotherapy Cell Cell Biology Chemotherapy Dendritic Cell Imaging Immune System Immunology Laboratory Medical School Medicine Oncology Ph Research Surgery Technology Tumor

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer promotes oncology chief to lead R&D as activist Starboard circlesPfizer promotes oncology chief to lead R&D as activist Starboard circlesChris Boshoff played role in drugmaker’s acquisition of Seagen, which has been criticised by investor
Read more »

'Danger' Derby doctor intends to quit profession'Danger' Derby doctor intends to quit professionDr Jan Mozny failed six patients while working in Derby and Burton hospitals' oncology department.
Read more »

Maya Jama makes rare love life comment after Stormzy 'moves on' with popstarMaya Jama makes rare love life comment after Stormzy 'moves on' with popstarMaya Jama has shared an update on her relationship status after her ex-boyfriend Stormzy was seen kissing popster Victoria Monet.
Read more »

Maya Jama flaunts her incredible figure in a skintight white dress as she parties in Marbella -...Maya Jama flaunts her incredible figure in a skintight white dress as she parties in Marbella -...Love Island presenter Maya Jama, 29 let her hair down in a sexy white dress and cat-eye sunglasses as she partied in Ibiza with friends on thursday. The outing was just days after publicly announcing her split from Stormzy.
Read more »

Maya Jama looks incredible in bikini top and denim shorts on holiday with friends in Miami...Maya Jama looks incredible in bikini top and denim shorts on holiday with friends in Miami...Maya Jama stuns as she strips off to string bikini on last-minute holiday ahead of Love Island All Stars filming
Read more »

Maya Jama Reveals She's Ready to Marry and Start a Family After Split From StormzyMaya Jama Reveals She's Ready to Marry and Start a Family After Split From StormzyMaya Jama, Love Island host, shared her fitness journey after a month off and opened up about her future relationship goals. The 30-year-old revealed she's seeking a serious commitment, aiming to marry and have children with her next partner.
Read more »



Render Time: 2025-02-13 05:24:27